Purchase of 1,500 octaplaslg units for the united states marine corp
Ended Awarded
- Contract number
- HT942726FE101
- Awardee
-
Octapharma USA Inc. UEI FKJKNJVR1HV4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,800,000
Award facts
- Contract value 100% obligated
- $1,800,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Paramus, NJ 07652, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a delivery order to Octapharma USA Inc. on June 15, 2026, for 1,500 units of Octaplas LG with a ceiling value of $1.8 million and an ultimate completion date of September 16, 2026. The order supports the United States Marine Corps.
Octaplas LG is a solvent/detergent-treated liquid plasma product. Place of performance is Paramus, NJ. The order is priced firm fixed price with no set-aside.
Quick answers
Who was awarded contract HT942726FE101?
HT942726FE101 was awarded to Octapharma USA Inc. by Defense Health Agency (Department of Defense) on June 15, 2026.
How much is contract HT942726FE101 worth?
The government has obligated $1,800,000 on HT942726FE101.
Is contract HT942726FE101 an order under another contract?
Yes. HT942726FE101 is a delivery order under HT942525DE004, an indefinite delivery contract.
Was contract HT942726FE101 competed?
The extent of competition for HT942726FE101 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award